Iridex (IRIX) Divestments (2012 - 2013)

Iridex (IRIX) recorded quarterly Divestments of $510000.0 in Q2 2013, down 88.99% quarter-over-quarter from $4.6 million in Q1 2012.

Iridex (IRIX) Divestments (2012 - 2013) Analysis & Trends

Iridex's Divestments history runs 2 years deep, the most recent figure standing at $510000.0 for Q2 2013.

  • In Q2 2013, Divestments changed N/A year-over-year to $510000.0; the TTM figure through Dec 2013 stood at $510000.0 (down 88.99% YoY), while the FY2013 annual figure was $510000.0, down 88.99% from the prior year.
  • Divestments was $510000.0 for Q2 2013 at Iridex, down from $4.6 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $4.6 million in Q1 2012 to a low of $510000.0 in Q2 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.37 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Iridex 19.91 Mn 15.31 Mn 4.74 Mn -

Historic Data

Download Data
DateValue
Jun 29, 2013 510,000.00
Mar 31, 2012 4.63 Mn